Viewing Study NCT04973293


Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2026-04-12 @ 6:37 PM
Study NCT ID: NCT04973293
Status: RECRUITING
Last Update Posted: 2024-11-19
First Post: 2021-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer
Sponsor: Ruijin Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lung Neoplasm Malignant View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-small cell lung cancer View
None Neoadjuvant therapy View
None Immunotherapy View